NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 276 / 982

  1. Racial and Ethnic Differences in Initiation of Menthol Tobacco Smoking and Subsequent Tobacco Use in the Population Assessment of Tobacco and Health Study, Waves 1–4 (2013–2018)2023 · Crossref
  2. Racial and ethnic disparities in emergency department–initiated buprenorphine across five health care systems2023 · OpenAlex
  3. Racial and Ethnic Disparities in Opioid Access and Urine Drug Screening Among Older Patients With Poor-Prognosis Cancer Near the End of Life2023 · OpenAlex
  4. Racial and religious motives for drug criminalization2023 · Crossref
  5. Racial disparities in a community-based addiction reduction (CARE) program for women of reproductive age with substance use disorder2023 · Crossref
  6. Racial disparities in opioid use disorder and its treatment: A review and commentary on the literature2023 · Crossref
  7. Racial disparities in use of syringe service programs in King County, WA: a comparison of two cross-sectional surveys2023 · Crossref
  8. Racial Inequality in Receipt of Medications for Opioid Use Disorder2023 · OpenAlex
  9. Racial Inequities in Drug Tests Ordered by Clinicians for Pregnant People Who Disclose Prenatal Substance Use2023 · Crossref
  10. Racial/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City2023 · Crossref
  11. Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City2023 · Crossref
  12. Racial/Ethnic Disparity in Association Between Fetal Alcohol Syndrome and Alcohol Intake During Pregnancy: Multisite Retrospective Cohort Study2023 · Crossref
  13. RANCANGAN STRATEGI PENGEMBANGAN USAHA COFFEE SHOP MENGGUNAKAN METODE QUANTITATIVE STRATEGIC PLANNING MATRIX (QSPM) DAN BLUE OCEAN STRATEGY (BOS) DALAM UPAYA MEMPERTAHANKAN USAHA (STUDI KASUS: MEDIAN COFFEE AND EATERY)2023 · Crossref
  14. Randomised experiment for the effect of ‘Tobacco-Free Nicotine’ messaging on current e-cigarette users’ perceptions, preferences and intentions2023 · Crossref
  15. Randomized Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients2023 · OpenAlex
  16. Rapamycin Augmentation of Chronic Ketamine as a Novel Treatment for Complex Regional Pain Syndrome2023 · OpenAlex
  17. Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use2023 · OpenAlex
  18. Rapid analysis of amphetamine‐type substances using Agilent's QuickProbe gas chromatograph/mass spectrometer technology2023 · OpenAlex
  19. Rapid Analysis of Drugs: A Pilot Surveillance System To Detect Changes in the Illicit Drug Supply To Guide Timely Harm Reduction Responses — Eight Syringe Services Programs, Maryland, November 2021–August 20222023 · OpenAlex
  20. Rapid analysis of urine using mass spectrometry with atmospheric pressure laser plasma ionization2023 · Crossref
  21. Rapid and On-Scene Chemical Identification of Intact Explosives with Portable Near-Infrared Spectroscopy and Multivariate Data Analysis2023 · OpenAlex
  22. Rapid desorption and analysis for illicit drugs and chemical profiling of fingerprints by SICRIT ion source2023 · Crossref
  23. Rapid Determination of Nutmeg Shell Content in Ground Nutmeg Using FT-NIR Spectroscopy and Machine Learning2023 · OpenAlex
  24. Rapid evidence profile #57: Examining the use of psychedelic-assisted psychotherapy for Veterans2023 · OpenAlex
  25. Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective, observational cohort study2023 · OpenAlex
  26. Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression2023 · OpenAlex
  27. Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actions2023 · OpenAlex
  28. Rapid opioid overdose response system technologies2023 · OpenAlex
  29. Rapid screening of 2‐benzylbenzimidazole nitazene analogs in suspect counterfeit tablets using Raman, SERS, DART‐TD‐MS, and FT‐IR2023 · OpenAlex
  30. Rapid Simultaneous Determination of 11 Synthetic Cannabinoids in Urine by Liquid Chromatography-Triple Quadrupole Mass Spectrometry2023 · OpenAlex
  31. Rapidly Adapting a Multicomponent Treatment for Persons Experiencing Chronic Homelessness with Comorbid Substance Use and Mental Health Disorders During the Coronavirus Disease 2019 Pandemic2023 · Crossref
  32. Rat Grimace Scale as a Method to Evaluate Animal Welfare, Nociception, and Quality of the Euthanasia Method of Wistar Rats2023 · OpenAlex
  33. Re-evaluating benzodiazepines for anxiety disorders – déjà-vu all over again?2023 · Crossref
  34. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging.2023 · PubMed
  35. Real or fake? Sourcing and marketing of non‐prescribed benzodiazepines amongst two samples of people who regularly use illicit drugs in Australia2023 · Crossref
  36. Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder2023 · OpenAlex
  37. Real-world Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients with Opioid Use Disorder during the COVID-19 Pandemic2023 · OpenAlex
  38. Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study2023 · OpenAlex
  39. Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG2023 · OpenAlex
  40. Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada2023 · Crossref
  41. Reasonable expectations for replications of psychedelic-assisted therapy: The case for prediction intervals rather than P-values2023 · Crossref
  42. Reasons for not entering opioid agonist treatment: A survey among high-risk opioid users in Finland2023 · OpenAlex
  43. Reasons, Form of Ingestion and Side Effects Associated with Consumption of Amanita muscaria2023 · Crossref
  44. Receipt and use of prohibited free samples of tobacco products among US adults who use cigarettes, cigars and smokeless tobacco, 20202023 · Crossref
  45. Receipt of Prescription Psychostimulants and Stimulant-Involved Fatal Overdose: A Population-Based Case-Control Study2023 · OpenAlex
  46. Receiving and providing virtual harm reduction and peer-based support2023 · OpenAlex
  47. Recent advancements in identification and detection of saliva as forensic evidence: a review2023 · Crossref
  48. Recent advances in the study of anesthesia-and analgesia-related mechanisms of S-ketamine2023 · OpenAlex
  49. Recent advances of the causal agent of yellow leaf disease (YLD) on areca palm (Areca catechu L.)2023 · OpenAlex
  50. Recent Developments in Pharmacotherapy of Depression: Bench to Bedside2023 · OpenAlex
  51. Recent developments involving psychedelics2023 · OpenAlex
  52. Recent findings and advancements in the detection of designer benzodiazepines: a brief review2023 · Crossref
  53. Recent Incarceration, Substance Use, Overdose, and Service Use Among People Who Use Drugs in Rural Communities2023 · OpenAlex
  54. Recent insights into the hepatoprotective potential of medicinal plants and plant‐derived compounds2023 · OpenAlex
  55. Recent modifications to the US methadone treatment system are a Band-Aid—not a solution—to the nation's broken opioid use disorder treatment system2023 · Crossref
  56. Recent patent applications for coffee and coffee by‐products as active ingredients in cosmetics2023 · Crossref
  57. Recent Research Advancements of Coffee Quality Detection: Targeted Analyses vs. Nontargeted Fingerprinting and Related Issues2023 · OpenAlex
  58. Recent Research on Cannabis sativa L.: Phytochemistry, New Matrices, Cultivation Techniques, and Recent Updates on Its Brain-Related Effects (2018–2023)2023 · Crossref
  59. Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice2023 · OpenAlex
  60. Receptor specific mechanisms underlying psychedelic effects on affective behaviors2023 · Crossref
  61. Recidivism of Individuals Who Completed Schedule I Drugs Deferred Prosecution Treatment: A Population-Based Follow-Up Study from 2008 to 2020 in Taiwan2023 · OpenAlex
  62. Recommandation par les infirmières en oncologie concernant la prise de cannabis au Canada pour soulager les nausées et les vomissements induits par la chimiothérapie : étude des facteurs d’influence2023 · Crossref
  63. Recommendation for Cannabis Use Disorder Diagnosis in a Context of Cannabis for Therapeutic Purposes2023 · Crossref
  64. Recommendation: ‘Lost Women of Science’ and Marie Nyswander2023 · Crossref
  65. Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants2023 · OpenAlex
  66. Reconsidering Context in Psychedelic Research: Rituals as Ancient Libraries of Knowledge2023 · OpenAlex
  67. Record linkage studies of drug-related deaths among adults who were released from prison to the community: a scoping review2023 · OpenAlex
  68. Recount and Account of Lived Experience of Children on the Street: A Phenomenology Approach2023 · Crossref
  69. Recovering Individuals’ Feelings About Addict and Alcoholic as Stigmatized Terms: Implications for Treatment2023 · Crossref
  70. Recovery from Addictions in Europe: Theory, Models and Methods2023 · Crossref
  71. Recovery homes called out for not allowing MOUD in violation of civil rights laws2023 · Crossref
  72. Recovery Ready Workplaces: A key strategy for reducing overdoses and sustaining recovery from substance use disorder2023 · Crossref
  73. Recovery Support and Capacity Assessment Using the Calculating an Adequate System Tool: Two Case Studies2023 · Crossref
  74. Recreational Cannabis Legalization and Adolescent Sexual Risk Behaviors2023 · Crossref
  75. Recreational cannabis legalization has had limited effects on a wide range of adult psychiatric and psychosocial outcomes2023 · Crossref
  76. Recreational Cannabis Legislation: substance use and impaired driving among Canadian rural and urban postsecondary students2023 · Crossref
  77. Recreational Cannabis Use: Regulatory Aspects, Public Opinion and Concerns for Public Health2023 · Crossref
  78. Recreational drug-use as an urban source of nitrous oxide2023 · OpenAlex
  79. Recruiting and Retaining a Diverse and Skilled Addiction Treatment Workforce2023 · Crossref
  80. Recruitment discrimination of lifetime classic psychedelic users is unjustified: Evidence from employees' motivation-based workplace absenteeism2023 · Crossref
  81. Recuperación de suelo abandonado ex cocal (Erythroxylum coca var. coca) mediante el manejo orgánico de sábila (Aloe vera barbadensis M.), en Nor Yungas de Bolivia2023 · Crossref
  82. Recurrent cerebral intraparenchymal hemorrhage after ayahuasca consumption: a case report2023 · OpenAlex
  83. Recurrent Psychotic Episodes Induced by Synthetic Cathinones in a Monozygotic Twin with Drug Addiction: A Case Report2023 · Crossref
  84. Red Betel Leaf Bioactive Compounds as ERα Receptor Inhibitors In Silico and MCF-7 Cell Anticancer In Vitro2023 · Crossref
  85. Reddit language indicates changes associated with diet, physical activity, substance use, and smoking during COVID-192023 · OpenAlex
  86. Redefining and categorizing emergency medical service opioid‐related incidents in Massachusetts2023 · Crossref
  87. Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression2023 · OpenAlex
  88. Reduced death anxiety as a mediator of the relationship between acute subjective effects of psychedelics and improved subjective well-being2023 · OpenAlex
  89. Reducing alcohol use through alcohol control policies in the general population and population subgroups: a systematic review and meta-analysis2023 · OpenAlex
  90. Reducing drinking: A harm reduction goal for AUD2023 · Crossref
  91. Reducing Drug Overdose Deaths: Significant Changes Needed in U.S. Drug Treatment Policy2023 · Crossref
  92. Reducing Fear to Help Build Healthy Families: Investing in Non-Punitive Approaches to Helping People with Substance Use Disorder2023 · Crossref
  93. Reducing nitrate and tobacco‐specific nitrosamine level in burley tobacco leaves through grafting on flue‐cured tobacco rootstock2023 · Crossref
  94. Reducing opioid related deaths for individuals who are at high risk of death from overdose: a co-production study with people housed within prison and hostel accommodation during Covid-192023 · OpenAlex
  95. Reducing the Harms of Nonclinical Psychedelics Use Through a Peer-Support Telephone Helpline2023 · Crossref
  96. Reducing the harms of xylazine: clinical approaches, research deficits, and public health context2023 · Crossref
  97. Reduction of alcohol use and increase in psychological flexibility after a naturalistic psychedelic experience: a retrospective survey2023 · Crossref
  98. Reduction of compulsive overeating in rats caused by maternal deprivation in early ontogenesis with the use of a new ghrelin receptor antagonist agrelax2023 · Crossref
  99. Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review2023 · OpenAlex
  100. Reexploring Female Pathways to Incarceration: Assessing the Role of Mental Illness2023 · Crossref